Page last updated: 2024-08-24

baicalin and Bone Cancer

baicalin has been researched along with Bone Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Ding, SC; Dong, X; Li, N; Mai, YX; Pang, FX; Wang, JY; Wen, RJ; Zhang, JF; Zhou, ST; Zhuang, HW1
Fang, Q; Ge, H; Huang, T; Li, M; Wang, B; Yuan, J; Zhang, X1
Chai, Y; Lu, S; Ma, Z; Wang, H; Wang, Y; Zhong, W; Zhou, R1

Other Studies

3 other study(ies) available for baicalin and Bone Cancer

ArticleYear
Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Jul-25, Volume: 116

    Topics: Animals; Bone Neoplasms; Disease Models, Animal; Ferroptosis; Glutathione Disulfide; Humans; Mice; NF-E2-Related Factor 2; Osteosarcoma

2023
Bone-protective and anti-tumor effect of baicalin in osteotropic breast cancer via induction of apoptosis.
    Breast cancer research and treatment, 2020, Volume: 184, Issue:3

    Topics: Animals; Apoptosis; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Flavonoids; Humans; Mice; Osteoclasts; Quality of Life; Tumor Microenvironment

2020
Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-β1-induced epithelial-to-mesenchymal transition.
    Anti-cancer drugs, 2017, Volume: 28, Issue:6

    Topics: Anoikis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Flavonoids; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Osteosarcoma; Phosphorylation; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1

2017